|
WO2021076570A2
|
|
Chagas disease vaccine antigens with improved stability and decreased aggregation
|
|
WO2021062025A2
|
|
Learning from biological systems how to regularize machine-learning
|
|
WO2021041924A2
|
|
System for regulating gene expression
|
|
WO2021034674A1
|
|
Third party virus-specific t cell compositions, and methods of making and using the same in anti-viral prophylaxis
|
|
WO2021030460A1
|
|
Proteogenomic methods for diagnosing cancer
|
|
WO2021021937A1
|
|
Antigen-specific t cell banks and methods of making and using the same therapeutically
|
|
WO2020264096A1
|
|
Systems and methods for generating bacteriophages adapted to infect a target bacterial strain
|
|
WO2020264005A1
|
|
Multifunctional biomesh for surgical hernia repair
|
|
WO2020257734A1
|
|
Compounds, compositions, and methods for treating, ameliorating, or preventing bacterial infections
|
|
WO2020252397A1
|
|
Small molecule proteolysis-targeting chimeras and methods of use thereof
|
|
WO2020232277A1
|
|
Uses of a2 domain of von willebrand factor
|
|
WO2020219627A1
|
|
Surgically implanted mechanical bladder-assist device
|
|
WO2020219773A1
|
|
Systems and methods for measuring and monitoring intracranial pressure
|
|
WO2020210437A1
|
|
Fetoscopic microsuturing device
|
|
WO2020210428A1
|
|
Novel inhibitors of flavivirus protease for prevention and treatment of zika, dengue and other flavivirus infections
|
|
WO2020206179A1
|
|
Method and system for detection and analysis of thoracic outlet syndrome (tos)
|
|
WO2020198366A1
|
|
Multi-respiratory virus antigen-specific t cells and methods of making and using the same therapeutically
|
|
WO2020190940A1
|
|
Direct reprogramming of cardiac fibroblasts into cardiomyocytes using an endothelial cell transdifferentiation strategy
|
|
WO2020180557A1
|
|
Devices and methods for measuring brain state
|
|
US2020260969A1
|
|
Method of predicting fluid responsiveness in patients
|
